Early research (Phase 1)UnknownNCT04798001
What this trial is testing
Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults
Who this might be right for
Covid19
Meissa Vaccines, Inc. 130